Display Settings:

Format

Send to:

Choose Destination
    Chem Biol Drug Des. 2007 Sep;70(3):268-72.

    Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.

    Source

    Pfizer Research Technology Center, 620 Memorial Drive, Cambridge, MA 02139, USA. cyrille.f.kuhn@pfizer.com

    Abstract

    A cell-based assay for the chemokine G-protein-coupled receptor CCR4 was developed, and used to screen a small-molecule compound collection in a multiplex format. A series of bipiperidinyl carboxylic acid amides amenable to parallel chemistry were derived that were potent and selective antagonists of CCR4. One prototype compound was shown to be active in a functional model of chemotaxis, making it a useful chemical tool to explore the role of CCR4 in asthma, allergy, diabetes, and cancer.

    PMID:
    17718722
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk